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IGF-1–induced lipid accumulation impairs mesangial cell mi- cells (VSMC) [1]. Like VSMC, mesangial cells express
gration and contractile function. low-density lipoprotein (LDL) and scavenger receptors
Background. Chronic treatment of mesangial cells with insu- [2], and they secrete increased amounts of extracellularlin-like growth factor-1 (IGF-1) results in intracellular lipid
matrix [3, 4] and monocyte chemoattractant protein-1accumulation. These mesangial cells resemble foam cells.
[5] in response to oxidized LDL. Similarities betweenMethods. To determine whether this phenotype affects cell
function, lipid-laden mesangial cells were tested for their ability progressive glomerulosclerosis, particularly focal sclero-
to migrate in response to IGF-binding protein-5 (IGFBP-5) sis, and arteriosclerosis suggest that these two entities
and to contract in response to angiotensin II (Ang II). IGFBP-5 may share pathogenic mechanisms [6, 7], which rely, inbinding and subsequent activation of the signal transduction
part, on cellular abnormalities in lipid uptake.cascade for migration were examined. To confirm that lipid
Previous studies from our laboratory have defined theaccumulation was responsible for impaired contractility, lipid
was removed from lipid-laden mesangial cells and the cells influence of insulin-like growth factor-1 (IGF-1) on mes-
were re-tested for contractile response to Ang II. angial cell biology and examined the independent and
Results. In comparison to control mesangial cells, lipid-laden
interactive effects of IGF-1 and IGF-binding protein-5cells failed to migrate in response to IGFBP-5. Although cellu-
(IGFBP-5). IGF-1 binds to the type 1 receptor on mesan-lar binding of IGFBP-5 was not altered by lipid accumulation,
IGFBP-5 failed to activate cdc42, a Rho GTPase required gial cells and simulates mesangial cell proliferation [8].
for IGFBP-5-mediated mesangial cell migration. These data IGF-1 stimulates mesangial cell migration by inducing a
indicate that lipid accumulation within the mesangial cell inter- kite-shaped phenotype with a -actin-rich leading la-
feres with the signal transduction response to IGFBP-5. In
mella that propels the cell toward an IGF-1 concentra-addition, mesangial cells treated with IGF-1 had reduced con-
tion gradient [9, 10]. IGF-1-induced migration requirestraction to Ang II. When lipid accumulation was exaggerated
by adding cholesteryl esters to the culture medium, mesangial interaction between v3 integrins and fibronectin [9].
cells failed to contract in response to Ang II. Following removal These effects of IGF-1 are inhibited by intact IGFBP-5,
of excess lipid from these mesangial cells, the contractile re- which binds to IGF-1. In addition to interactive effects
sponse to Ang II was restored.
with IGF-1, IGFBP-5 has independent effects that areConclusions. IGF-1 induces lipid accumulation in mesangial
mediated by the heparin-binding domain, which bindscells, which impairs their ability to respond to specific migratory
and contractile stimuli. These observations are relevant to un- to a putative IGFBP-5 receptor [9, 11]. IGFBP-5 inhibits
derstanding functional abnormalities in diseases where mesan- mesangial cell proliferation by direct activation of the
gial foam cells occur, such as focal and segmental glomerulo- IGFBP-5 receptor and by inhibiting the mitogenic effectssclerosis and diabetic nephropathy.
of IGF-1. Furthermore, IGFBP-5 stimulates mesangial
cell migration by a different mechanism than IGF-1.
IGFBP-5 induces a spider-like morphology that migratesThe glomerulus is a highly specialized vascular struc-
using a 1 integrin [11]. These IGF-1-independent effectsture in which mesangial cells serve as specialized peri-
of IGFBP-5 can be reproduced with the IGFBP-5201-218cytes sharing properties with vascular smooth muscle
peptide, which does not inhibit IGF-1 activity.
Recently, we observed that rat mesangial cells cultured
in IGF-1 (100 nmol/L) for 1 to 4 weeks become lipid-Key words: mesangial cell, IGF-1, IGFBP-5, contraction, migration,
atherosclerosis, lipids, glomerulosclerosis. laden and develop a foam cell appearance [12]; thus,
like VSMC in arteriosclerosis, inflammatory cytokines,Received for publication December 28, 2001
including IGF-1, contribute to foam cell formation [13].And in revised form March 29, 2002
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capacity [12]. Our studies showed that IGF-1 stimu- studied in triplicate and entire experiments were re-
peated at least once. Quantitative data were analyzedlates an increase in lipid particle uptake predominately
through fluid-phase endocytosis [12]. Within the glomer- by ANOVA. P  0.05 was considered significant.
ulus, mesangial cells provide structural support through
Cell culturesynthesis of extracellular matrix [14, 15] and they migrate
in response to injury [9, 16], while regulating blood flow Rat glomerular mesangial cells were prepared by mod-
ification [14, 15] of routine methods [20]. Minced ratand capillary tension using contractile forces [17]. The
present studies were undertaken to determine the ability kidney cortex was sieved. Isolated glomeruli were plated
in medium containing a 1:1 mix of 20% FCS-RPMI 1640of lipid-laden mesangial cells to migrate in response to
IGFBP-5 and to contract in response to angiotensin II and previously collected glomerular-conditioned me-
dium. Mesangial cell outgrowths were harvested and(Ang II).
passed in this medium for an additional week, after which
the conditioned medium was omitted. Insulin routinely
METHODS
added to mesangial cell cultures was not included.
Materials
Migration assayThe following reagents were purchased: Nile red, cho-
lesteryl esters (Molecular Probes, Eugene, OR, USA); To measure migration, mesangial cells were plated in
60 mm tissue culture dishes, grown to near confluencemonoclonal mouse anti-cdc42GAP (Transduction Labo-
ratories, Lexington, KY, USA); Cy 3-rabbit anti-mouse in growth medium and then growth arrested for 48 hours
in medium containing 2% FCS. A portion of the plateIgG (Jackson Labs, West Grove, PA, USA); chambered
tissue culture glass slides (NUNC, Naperville, IL, USA); was denuded of cells by scraping with a sterile razor
blade creating a linear wound edge across the dish [9].Fluoromount (Fisher Scientific, Pittsburgh, PA, USA);
polydimethysiloxane and angiotensin II (Sigma Bio- Migration was measured in untreated mesangial cells or
after the addition of IGFBP-5201-218 (30 g/mL). Forty-chemical, St. Louis, MO, USA); human recombinant
IGF-1 (Collaborative Research, Waltham, MA, USA), eight hours later, cultures were stained with 3% toluidine
blue and migrating cells were counted along a 1 mmintact human recombinant IGFBP-5 (Chiron Corp.,
Emeryville, CA, USA), IGFBP-5 peptide (AA201-218, length of the wound edge. Five areas were examined per
sample and each condition was studied in triplicate. DataRKGFYKRKQCKPSRGRKR) (Fred Hutchinson Can-
cer Research Center, Seattle, WA, USA); 125I, chlora- were analyzed as the total number of migrating cells.
Data were expressed as a percent of control and groupsmine T (Amersham, Piscataway, NJ, USA).
were compared by ANOVA. Mesangial cells that had
Experimental design been untreated or chronically cultured in IGF-1 (100
nmol/L), with or without cholesteryl esters (2.5 g/mL),Four groups of mesangial cells were studied. Mesan-
gial cells were untreated or treated with IGF-1 (100 were examined in the migration assay.
nmol/L) for 1 week in standard culture medium [20%
125I-IGFBP-5 bindingfetal calf serum (FCS)-RPMI 1640]. Half of each of these
cultures had cholesteryl esters (2.5 g/mL) added to IGFBP-5 binding was determined as described pre-
viously [9, 21]. Briefly, mesangial cells (4  104) werethe medium. All groups were placed in growth-arrest
medium (2% FCS-RPMI 1640) for 48 hours before each incubated with 100,000 counts per minute (CPM) of 125I-
IGFBP-5 with and without increasing concentrations oftest. Cells were stained with Nile red to determine lipid
accumulation [18]. To test the migratory response, each unlabeled intact IGFBP-5 or IGFBP-5201-218 for 2 hours
at 4C. The cells were rinsed with phosphate-bufferedgroup of cells was exposed to IGFBP-5201-218, the heparin-
binding domain that mediates independent effects of saline (PBS) and solubilized with 1N NaOH. Radioactiv-
ity of the cell lysates was determined and specific bindingIGFBP-5 and does not inhibit IGF-1 [9]. The number
of migrating cells was determined 48 hours later. To was computed by subtracting background counts from
total CPM. Each concentration of unlabeled materialexamine the mechanism responsible for alteration in the
migratory response, IGFBP-5 binding and Cdc42 activa- was examined in triplicate.
tion were determined. To examine the contractile re-
Activation of Cdc42sponse, each group of mesangial cells was treated with
Ang II. Contraction was determined by observing wrin- Previous studies have shown that IGFBP-5 stimulates
filopodia formation and mesangial cell migration by acti-kling of a siloxane membrane and by measuring a change
in planar surface area. To confirm the role of lipid accu- vation of a member of the Rho family of GTPases, Cdc42
[11]. Mesangial cells grown under experimental condi-mulation in mediating the abnormal contractile re-
sponse, lipid accumulation was reversed [19] and the tions as described above were treated with IGFBP-5201-218
(30 g/mL) for 1 hour. Upon activation, Cdc42 bindsresponse to Ang II was retested. All conditions were
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to its regulatory protein, Cdc42GAP [22, 23], to form
aggregates that shift from the sub-membrane area to the
perinuclear region of the cell. To identify the activation
and shift in location of Cdc42, cultures were stained with
antibody to Cdc42GAP and identified by a Cy 3-con-
jugated secondary antibody.
Mesangial cell contraction
Ang II-stimulated mesangial cell contraction was mea-
sured by wrinkling of silicone rubber [24, 25] and by
changes in planar surface area [26]. Polydimethysiloxane
was spread onto a sterile coverslip, polymerized over an
open flame, rinsed, and dried. Mesangial cells from each
group (2  104/mL) were plated onto these coverslips
in 20% FCS-RPMI 1640 for 24 hours. After attachment,
mesangial cells were growth arrested for 48 hours. A
separate set of experiments was performed in which mes-
angial cells were cultured, plated on silicone, and growth
arrested as described above. This was followed by incu-
bation with 10% fatty acid-free albumin in 2% FCS-
RPMI 1640 for 48 hours to remove the excess lipid that
had accumulated during the initial culture with IGF-1
and cholesteryl esters [19]. Mesangial cell contraction
was stimulated by Ang II (100 mol/L) and, 30 minutes
later, contraction was observed as wrinkling of the sili-
cone. Cells were photographed with a Polaroid Land
camera (Polaroid Corp., Cambridge, MA, USA) on a
Leitz (Leitz, Inc., Rockleigh, NJ, USA) inverted micro-
scope. In separate experiments, contraction was also
quantified by measuring the change in planar surface
area of individual mesangial cell plated in tissue culture
dishes [26]. Ang II (100 mol/L) was added to induce
contraction and images were captured using a Hama-
matsu video camera (Sanyo Corp., Tokyo, Japan) and
stored in a time-lapse video system at 0, 5, 10, and 20
minutes. Video images of 5 cells per condition were
transported into a Power Macintosh computer (Apple,
Inc., Cupertino, CA, USA) with a video capture card.
Images were measured and changes in planar surfaces
were calculated using NIH-Image.
Fluorescence microscopy
Chamber slides were rinsed in PBS and fixed in 2%
paraformaldehyde, and permeabilized with 0.05% triton
X-100. Slides were incubated with primary antibody,
rinsed and incubated with Cy 3-conjugated secondary
Fig. 1. Mesangial cells used in functional assays are shown by lightantibody. Bodipy phalloidin was used to identify F-actin. microscopy and after staining with Nile red (inserts). (a) Untreated
Controls included the non-immune IgG and the second- mesangial cells. (b) Mesangial cells cultured with insulin growth fac-
tor-1 (IGF-1) for 1 week. (c) Mesangial cells cultured with IGF-1 andary antibody alone. Mesangial cells were mounted in
cholesteryl esters (2.5g/mL) for 1 week. The arrows show lipid droplets
Fluoromount and observed with a Leitz microscope that are visible by light microscopy. The amount of lipid is increased with
IGF-1 and exaggerated by addition of lipids to the medium. Originalequipped with epi-illumination. The fluorescent images
magnification 400.were recorded on Kodak DX 400 black and white film
or on Ektachrome film.
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RESULTS
Lipid accumulation in mesangial cells
The mesangial cells used in the functional assays are
shown in Figure 1. Phase contrast microscopy shows
vacuoles in mesangial cells treated with IGF-1 (Fig. 1b),
which are more prominent when the IGF-1-containing
medium was also supplemented with cholesteryl esters
(Fig. 1c). The lipid content of these vacuoles was con-
firmed by staining with Nile red, which showed that the
IGF-1-treated cells had considerably more intracellular
lipid than can be detected by light microscopy. This is
comparable to the diffuse lipid droplets that we pre-
viously reported by electron microscopy [12]. Untreated
mesangial cells or those supplemented with cholesteryl
esters without IGF-1 (not shown) do not accumulate
Fig. 2. Mesangial cell migration. Prior to testing, mesangial cells were
lipid intracellularly. propagated untreated or with chronic insulin growth factor-1 (cIGF-1)
and IGF-1 plus cholesteryl esters (IGF-1  ce). Using a wounding
assay, migration was in unstimulated mesangial cells () or in mesangialLipid-laden mesangial cells have impaired migration in
cells stimulated by the addition of insulin growth factor binding proteinresponse to IGFBP-5 (IGFBP-5201-218 ) (30 g/mL) ( ). Results are expressed as percent of
control. Mean  1 SD is plotted. Groups were compared by ANOVA.In previous studies we have shown that mesangial cells
*P  0.05.migrate in response to IGF-1 and the heparin-binding
domain IGFBP-5 [9, 11]. Yet, the mechanisms that
mediate migration differ with these two stimuli. IGF-1- eryl ester mesangial cells fail to migrate when stimulated
induced cytoskeletal reorganization and cell migration with IGFBP-5201-218, we wondered if this was due to al-
is mediated by Rac-1 activation, whereas IGFBP-5-medi- tered IGFBP-5 receptor expression. As shown in Figure
ated migration has little Rac-1 activation, but requires 3, cellular binding of labeled IGFBP-5 is not statistically
activation of the Cdc42 cascade [11]. In acute studies, different in untreated, cIGF-1-treated or cIGF-1 plus
both IGF-1 and IGFBP-5201-218 increase mesangial cell cholesteryl ester-treated mesangial cells. In all cases, un-
migration by 2.0 to 2.5 fold; however, when the two labeled intact IGFBP-5 and IGFBP5201-218 peptide shown
stimuli are added together, there is a 3.5-fold increase comparable degrees of competition for the labeled li-
in migration. As Rac-1 can lead to Cdc42 activation, gand. These data indicate that there were no differences
synergistic action of IGF-1 and IGFBP-5 may amplify in IGFBP-5 binding for either the intact protein or the
these signal transduction cascades. In the current studies, heparin-binding domain (AA201-218), which is believed
IGF-1-treated mesangial cells were propagated in IGF-1 to mediate binding to its receptor [21]. As IGFBP-5
for 7 days, but subsequent quiescent media and assays binding is unchanged, it is not likely that receptor expres-
are without IGF-1. Mesangial cells propagated in routine sion is responsible for the migration failure of the lipid-
medium or medium supplemented with cholesteryl es- laden, cIGF-1  cholesteryl ester MC.
ters (not shown) responded normally to migration in-
IGFBP-5201-218 fails to activate Cdc42 in lipid-ladenduced by IGFBP-5201-218 (Fig. 2). Mesangial cells chroni-
mesangial cellscally exposed to IGF-1 (cIGF-1 mesangial cells) migrated
in response to IGFBP-5201-218 to a similar degree as un- IGFBP-5-mediated migration is characterized by ex-
treated mesangial cells; however, the additive effects that tensive filopodia formation and activation of the Rho
were observed in acute studies [11] were not seen here. GTPase, Cdc42 [11]. When IGFBP-5 receptor signal
When lipid accumulation was increased in cIGF-1 mes- transduction is blocked by a serine-threonine kinase in-
angial cells by the addition of cholesteryl esters to the hibitor, Cdc42 is not activated and mesangial cells no
medium (cIGF-1 cholesteryl ester), migration induced longer migrate in response to IGFBP-5 [11]. To investi-
by IGFBP-5201-218 was significantly reduced as compared gate the early steps in IGFBP-5-mediated mesangial cell
to the other groups. migration, we stained for Cdc42GAP, which binds only
to activated Cdc42 and becomes aggregated around the
125I-IGFBP-5 binding to mesangial cells nucleus when Cdc42 is activated [11]. In untreated mes-
IGFBP-5-induced mesangial cell migration requires angial cells without IGFBP-5, Cdc42GAP staining is
cellular binding of IGFBP-5 and activation of a putative faint and diffuse throughout the cell (Fig. 4a). After 1
receptor having serine-threonine kinase activity [9, 11]. hour of treatment with IGFBP-5201-218, as an indication
of Cdc42 activation, Cdc42GAP staining was bright andAs the above experiments showed that cIGF-1 cholest-
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and faint in cIGF-1  cholesteryl ester mesangial cells
stimulated by IGFBP-5201-218 (Fig. 4d). These results indi-
cate that stimulation of lipid-laden mesangial cells with
IGFBP-5 fails to induce Cdc42 activation. As IGFBP-5
binding was unchanged in these cells, it suggests that
lipid accumulation alters the signal transduction cascade
that is required for IGFBP-5-induced mesangial cell mi-
gration. The effects of cholesteryl esters was not simply
a toxic effect, but required intracellular accumulation,
as untreated mesangial cells exposed to cholesteryl esters
for 7 days show a pattern of aggregation of Cdc42GAP
consistent with activation by IGFBP-5201-218 (not shown).
Lipid-laden mesangial cells fail to contract in response
to Ang II
Mesangial cells modulate intraglomerular hemody-
namics through contraction, which altars the dimensions
of the capillary lumen and intracapillary pressures. To
measure contraction, a mesangial cell was plated on sili-
cone sheets, treated with Ang II, and the wrinkling of
the silicone membrane was quantified. Control mesan-
gial cells wrinkled the membrane within 30 minutes of
treatment with Ang II (Fig. 5). This response was unaf-
fected by exposure of control mesangial cells to chol-
esteryl esters. In contrast, cIGF-1 mesangial cells and
cIGF-1  cholesteryl ester mesangial cells failed to con-
tract in response to Ang II.
Contraction of individual mesangial cells was evalu-
ated by planar measurements taken over a period of
time (Fig. 6). Surface areas of cells were measured at 0,
5, and 20 minutes after the addition of Ang II. Minimal
contraction of mesangial cells was seen at 5 minutes
after the addition of Ang II, but full contraction was
measurable by 20 minutes. Mesangial cells without added
Ang II (untreated mesangial cells) did not contract. In
keeping with the visual appearance of mesangial cells
wrinkling the silicone sheets, control mesangial cells and
those mesangial cells incubated in cholesteryl esters
changed their planar surface area after Ang II treatment,
but contraction was significantly impaired in cIGF-1 mes-
angial cells, and completely absent in the lipid-laden
cIGF-1  cholesteryl ester mesangial cells.
Fig. 3. IGFBP-5 binding. Mesangial cells were incubated with 125I- Although we have shown that IGF-1 leads to lipid
IGFBP-5 and increasing concentrations of unlabeled intact IGFBP-5 accumulation in mesangial cells, IGF-1 may have other
(A) or IGFBP-5201-218 peptide (B). Mesangial cells were untreated (),
effects that impair contractility in mesangial cells. Totreated with IGF-1 (100 nmol/L) (), or treated with IGF-1 (100
nmol/L) plus cholesteryl esters (2.5 g/mL) (). There were no statisti- investigate the role of lipid accumulation in the abnormal
cally significant differences in the competition curves. contractile response to Ang II, lipid accumulation was
reversed and the cells were retested for their ability to
contract. After culture of mesangial cells with cholesteryl
showed aggregation in a perinuclear distribution. After esters with or without IGF-1 for 7 days, lipid content
stimulation with IGFBP-5201-218, cIGF-1 mesangial cells was confirmed by Nile red staining. Excess lipid that had
also showed aggregation of Cdc42GAP (Fig. 4c). As the accumulated in the cell was removed by exposure to
cIGF-1 mesangial cells retained their ability to migrate fatty acid-free albumin as confirmed by the reduction in
in response to IGFBP-5201-218, activation of Cdc42 was Nile red staining. Mesangial cells that had been incu-
bated with cholesteryl esters followed by fatty acid-freeexpected. In contrast, Cdc42GAP staining was diffuse
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Fig. 4. Cdc42 activation. Cdc42GAP was iden-
tified by immunofluorescence microscopy. (a)
Unstimulated mesangial cells show a faint and
diffuse pattern of staining. (b) Mesangial cells
treated with IGFBP-5201-218 for 1 hour show
bright staining of Cdc42GA aggregates. (c)
Chronic IGF-1 mesangial cells treated with
IGFBP-5201-218. (d ) Chronic IGF-1 plus cholest-
eryl ester mesangial cells stimulated with
IGFBP-5201-218 show no significant staining for
Cdc42GAP. Original magnification 400.
Fig. 5. Mesangial cell contraction. Mesangial
cells (a), mesangial cells plus cholesteryl esters
(b ), chronic IGF-1 plus mesangial cell (c ),
and untreated IGF-1 plus cholesteryl ester (d )
were plated on silicone-coated coverslips and
stimulated with angiotensin II (Ang II) (100
nmol/L). Note the wrinkling of the silicone
rubber in (a) and (b), but its absence in (c)
and (d). Original magnification 400.
albumin showed normal Nile red staining and a normal DISCUSSION
contractile response to Ang II (Fig. 7a). Lipid-laden, Exposure of mesangial cells to IGF-1 for 1 to 4 weeks
cIGF-1  cholesteryl ester mesangial cells failed to con- induces a foam cell phenotype and this process is exag-
tract consistent with previous experiments, but this ac- gerated by adding cholesteryl esters to the culture me-
tion was reversed in cIGF-1  cholesteryl ester mesan- dium. We have previously shown that lipid-laden mesan-
gial cells in which the lipid had been removed (Fig. 7c), gial cells have a disrupted cytoskeleton and are unable
indicating that intracellular lipid accumulation, and not to engulf particles [12]. In the present studies, we extend
IGF-1, interferes with the contractile response of mesan- these observations to show that lipid-laden mesangial
cells are unable to migrate in response to IGFBP-5 andgial cells to Ang II.
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Fig. 6. Planar surface area. The change in planar cell surface area of
individual cells over time is plotted. Mesangial cells that did not receive
angiotensin II (Ang II) (; untreated mesangial cells) showed no change
in surface area. The change in area after the addition of Ang II is shown
for mesangial cells (), chronic IGF-1 plus mesangial cells (), and
chronic IGF-1 plus cholesteryl ester (). Measurements were taken
before and 5, 10, and 20 minutes after the addition of Ang II. Results
are plotted as the percent reduction in planar surface area. *P  0.0005
(ANOVA).
fail to contract normally in response to Ang II. Further-
more, these effects are specifically due to intracellular
lipid accumulation and not to IGF-1, since we show that
lipid removal restored the contractile response.
Impact of foam cell formation on mesangial
cell migration
Cell migration, which is important in development,
remodeling, and wound healing, was diminished in lipid-
laden mesangial cells, an effect that correlated with the
degree of lipid accumulation. IGF-1-treated mesangial
cells migrated in response to IGFBP-5; however, this
was not the case when lipid accumulation was increased
by chronic exposure to both IGF-1 and cholesteryl esters.
Without IGF-1 in the medium, cholesteryl esters did not
accumulate in mesangial cells or interfere with migration.
These observations exclude a toxic effect of cholesteryl
esters on the cells and indicate that IGF-1 is required
for cholesteryl ester uptake and accumulation. As chol-
esteryl esters in the medium alone did not accumulate
in mesangial cells or interfere with migration, these ob- Fig. 7. Mesangial cell contraction after removal of excess lipids. Mesan-
gial cells treated with delipidating fatty acid free albumin (a ), IGF-1servations exclude a toxic effect of cholesteryl esters on
plus mesangial cells (b), chronic IGF-1 plus mesangial cells after lipidthe cells and indicate that IGF-1 is required for cholest- removal (c ). Mesangial cells treated fatty acid free albumin showed a
eryl ester uptake and accumulation. The intracellular normal contractile response to angiotensin II (Ang II) (a). Lipid-laden
mesangial cells (chronic IGF-1 mesangial cells) showed no contractileaccumulation of lipid interfered with mesangial cell mi-
response (b). The contractile response to Ang II was restored by remov-
gration as stimulated by IGFBP-5. Because it was possi- ing excess lipid from lipid-laden mesangial cells (c). Notice areas of
wrinkling of silicone rubber in (a) and (c). Original magnification400.ble that chronic exposure to either IGF-1 or lipids altered
the IGFBP-5 receptor expression, IGFBP-5 binding was
measured. No differences in receptor expression were
found to account for the failure of lipid-laden mesangial
cells to migrate in response to IGFBP-5. Our previous
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work showed that IGFBP-5 binding activated the recep- matrix synthesis and composition [29], which in turn
tor serine-threonine kinase, which in turn activated modulates the contractile response [30]. Additional stud-
Cdc42 [11]. Consistent with the migratory response, all of ies will be required to define all of the mechanisms re-
the mesangial cell groups demonstrated Cdc42 activation sponsible for the inability of lipid-laden cells to contract.
except for the lipid-laden mesangial cells. These findings
Foam cells and renal diseaseindicate that lipid accumulation interferes with the signal
transduction cascade that is required for IGFBP-5-in- In a variety of renal diseases, mesangial cells become
duced migration. lipid-laden and develop into foam cells [3, 31]. Moreover,
The migratory response to IGFBP-5 in cells chroni- high levels of circulating lipids accelerate the progression
cally cultured with IGF-1 is complicated. There are sev- of renal disease [32], and treatment with low fat diets or
eral possible explanations for the normal migratory re- lipid-lowering agents ameliorate this effect [33]. In cell
sponse in IGF-1-treated mesangial cells showing modest culture, lipids stimulate mesangial cell release of cyto-
lipid accumulation. IGF-1 and IGFBP-5 stimulate mes- kines, including monocyte chemoattractant protein-1
angial cell migration by different mechanisms [9, 11], [34], and increase the synthesis of extracellular matrix
and in acute experiments when they are combined, the [35]. In turn, the extracellular matrix becomes a reservoir
migratory response is greater than either ligand alone. for lipid accumulation, where they later become oxidized
In mesangial cells that had been treated with IGF-1 for [3]. Oxidized lipoproteins are readily taken up by mesan-
1 week, the migratory response to IGFBP-5 was the gial cell scavenger receptors, further contributing to
same as with IGFBP-5 alone in untreated mesangial cells. foam cell formation [2]. In addition, mesangial cells ac-
Failure to see the additive effect of both ligands together tively oxidize LDL, which promotes renal injury [36]. In
may reflect a blunted response to IGFBP-5. The more many ways, mesangial cell reaction to lipid loading is
modest degree of lipid accumulation in IGF-1-treated analogous to the response of VSMC in large-vessel ath-
mesangial cells not supplemented with cholesteryl esters erosclerosis [37, 38]. In both situations, growth factors,
may not have been sufficient to impair the migratory inflammatory cytokines and lipids are required to stimu-
response to IGFBP-5. Alternatively, in these experi- late and maintain excess accumulation of extracellular
ments where IGF-1 is removed from the medium during matrix proteins in the presence of foam cells.
the growth arrest and wounding portions of the assay, Lipid accumulation has been demonstrated in human
some of the excess lipid may have dissipated, partially kidney biopsies from patients with a variety of glomeru-
reversing the effects of lipid accumulation. lar and interstitial diseases [31, 32, 39, 40] and it likely
contributes to glomerular injury in focal and segmentalMesangial cell contraction
glomerulosclerosis [41] and diabetic nephropathy [42]. InMesangial cells contract in response to a variety of
focal and segmental glomerulosclerosis, mesangial cellsstimuli, including Ang II [27, 28]. The contractile ability
become lipid laden to form a foam cell morphology [3],of mesangial cells influences the capillary wall surface
and in one small series, lipidpheresis has been associatedarea, which determines filtration capacity. Contraction of
with improvement in renal function [43]. In diabetic ne-the mesangium may also protect the glomerular capillary
phropathy, IGF-1 is overexpressed in injured glomeruliwall from excessive changes in pressure [17]. Mesangial
[44], and thus may initiate lipid loading in mesangialcells that become lipid-laden by treatment with IGF-1,
cells. The hyperlipidemia associated with diabetes maywith or without excess lipids in the medium, failed to
augment the degree of lipid accumulation. Subsequentcontract in response to Ang II, when compared to un-
extracellular matrix accumulation would be one re-treated mesangial cells. To confirm that lipid accumula-
sponse to the foam cell formation that eventually leadstion in the cell was responsible for the abnormal contrac-
to the fibrotic lesion. To our knowledge this is the firsttile response, cIGF-1 mesangial cells were delipidated
report of abnormal migratory and contractile responsesand were re-tested for their contractile response to Ang
of lipid-laden mesangial cells or VSMCs. AppropriateII. Lipid removal in the face of continued exposure to
contraction and relaxation of mesangial cells are criticalIGF-1 restored contractile response to Ang II, indicating
to maintaining glomerular filtration rate and protectingthat lipid accumulation was the cause of abnormal func-
the capillary wall from pressure-mediated injury andtioning of lipid-laden mesangial cells.
aneurysm formation. In models of mesangiolysis [26],Cell contraction requires a coordinated cytoskeleton
which also occurs in diabetic nephropathy [45], mesan-with intact stress fibers and focal adhesions that maintain
gial repair is dependent upon migration of mesangialequilibrium between external and internal forces. As we
progenitors from the extraglomerular mesangium. Thus,previously showed that lipid-laden mesangial cells have
IGF-1-mediated foam cell formation may impair con-a disrupted cytoskeleton [12], this may in part contribute
traction and migration and thereby contribute to mesan-to the abnormal contractile response that we observed.
Exposure of mesangial cells to IGF-1 alters extracellular gial cell dysfunction and renal disease progression.
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